SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Article
in En
| MEDLINE
| ID: mdl-30420616
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Cost-Benefit Analysis
/
Oxaliplatin
Type of study:
Clinical_trials
/
Health_economic_evaluation
Limits:
Humans
Language:
En
Journal:
Br J Cancer
Year:
2018
Type:
Article
Affiliation country:
United kingdom